Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110283180B reveals a mild Rhodium-catalyzed route to pyridine[3,4-c]coumarins, offering reliable pharmaceutical intermediate suppliers a cost-effective manufacturing solution.
Patent CN115057808A reveals a green Rh-catalyzed method for Z-isoindolinones. High stereoselectivity, no oxidants. Ideal for pharma intermediates supply.
Novel rhodium-catalyzed method offers high purity carbazole intermediates with scalable supply chain advantages for global pharmaceutical and electronic chemical manufacturing.
Patent CN106977445B details a mild, one-pot Rh(III)-catalyzed synthesis of benzo[a]carbazoles, offering significant cost reduction and supply chain reliability for electronic chemical manufacturing.
Novel Ni-catalyzed route for sulfur-containing isoindolinones offers high yield and green oxidation for reliable pharmaceutical intermediate supply chains and cost reduction.
Novel patent CN119285450A offers high-yield synthesis. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates. Ideal for scalable commercial production. Contact us for details.
Patent CN107641098A enables selective pyridone alkenylation using ruthenium catalysis. This method offers high yields and scalable production for pharmaceutical intermediate supply chains.
Novel Pd-catalyzed C-H activation route for benzopyran-3-ols. High yield, mild conditions. Cost-effective manufacturing for pharma intermediates.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Patent CN119530825B details cobalt-catalyzed electrochemical synthesis for high-purity chiral intermediates. Offers sustainable cost reduction and scalable supply chain solutions.
Patent CN110950739A reveals a mild, room-temperature photocatalytic method for ortho-fluorination. Ideal for high-purity pharmaceutical and agrochemical intermediates with reduced costs.
Patent CN108640945B reveals a novel Ru/Ir-catalyzed direct C-H alkynylation of amides. This method eliminates directing groups, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN113135852B details a metal-free route to 4-aminoquinoline intermediates. Achieve cost reduction in pharma manufacturing with mild conditions and high purity.
Patent CN109678911B details a high-efficiency Rh-catalyzed method for planar chiral ferrocene intermediates, offering superior enantioselectivity and supply chain reliability.
Patent CN106946817A enables transition-metal-free synthesis of 1,2-dihydronaphthalene derivatives. This method offers high atom economy and simplified supply chain for pharmaceutical intermediates.
Patent CN1209336C details a regioselective Pd-catalyzed halogenation process offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN110407830A reveals air-oxidized Cu-catalyzed route for N-aryl phenothiazine. Offers green manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN115043837A reveals a catalyst-free synthesis route for novel heterocyclic intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain stability.
Patent CN110054541B reveals a one-pot Pd-catalyzed method for high-purity deuterated aromatics, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN113292598A discloses a Rh(III)-catalyzed enantioselective synthesis of axial chiral biaryl compounds with P-stereocenters, offering significant supply chain advantages.